NeuroPsych Account Specialist openings?

[anonymous]

For one it’s a new sales force being assembled to lunch a new product.

 

[anonymous]

Is this new TD drug supposed to be a gamer?

 

[anonymous]

Is this new TD drug supposed to be a gamer?

There is no new drug for TD. Anticipating additional indication for Ingrezza in Huntington's Chorea in 2022-23, but no results yet. Expansion is for Parkinson's drug and added voice in LTC facilities with Ingrezza.

 

[anonymous]

New drug a lemon or is there hope?

 

[anonymous]

New drug a lemon or is there hope?

Sounds like another "Me Too" in an already crowded market.

 

[anonymous]

There is no new drug

 

[anonymous]

There is no new drug

By mid-2024 it's likly to be generic

 

[anonymous]

By mid-2024 it's likly to be generic

What does that mean?

 

[anonymous]

Zydus, Crystal, Lupin, and Teva all filed ANDAs and notified us their generic versions either don't violate our patents or that our patent claims are invalid.

We sued, which is industry standard. The patent challenges will play out over the next 30 months (by statute), which brings us to a crash landing in mid 2024

 

[anonymous]

Zydus, Crystal, Lupin, and Teva all filed ANDAs and notified us their generic versions either don't violate our patents or that our patent claims are invalid.

We sued, which is industry standard. The patent challenges will play out over the next 30 months (by statute), which brings us to a crash landing in mid 2024

Kevin called the lawsuits “business as usual.” He expressed complete confidence in patent protection at least through 2032.